Skip to main content
Log in

Force-frequency relationship and inotropic stimulation in the nonfailing and failing human myocardium: implications for the medical treatment of heart failure

  • Original Article
  • Published:
The clinical investigator Aims and scope Submit manuscript

Summary

In isolated papillary muscle strips from nonfailing donor hearts (NF) and from the hearts of patients with dilated cardiomyopathy with severe heart failure (NYHA IV), the force-frequency relationship was studied. Experiments were performed under basal conditions and in the presence of 0.01 μM or 0.1 μM isoprenaline and 0.02 μM ouabain. In NF, there was a positive inotropic effect following an increase of the stimulating frequency, whereas in NYHA IV, the force gradually declined under these conditions. Low concentrations (0.01) μM of isoprenaline prevented the negative inotropic effect in NYHA IV, whereas at 0.1 μM the mechanical function deteriorated in NF and NYHA IV. Ouabain had no effect on the force-frequency relationship compared to basal conditions. It is concluded that a reduction of high frequencies does improve the contractility in the failing myocardium. It is not unreasonable to speculate that this mechanism might be involved in the beneficial effects of drugs which reduce the heart rate, such as β-adrenoceptor antagonists and cardiac glycosides, in the condition of congestive heart failure in which the sympathetic tone is high.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

NF:

nonfailing myocardium

DCM:

dilated cardiomyopathy

SEM:

standard error of the mean

Hz:

hertz

NYHA IV:

functional class IV heart failure according to the New York Heart Association

CAMP:

cyclic 3′,5′-adenosine monophosphate

References

  1. Böhm M, Beuckelmann D, Brown L, Feiler G, Lorenz B, Näbauer M, Kemkes B, Erdmann E (1988) Reduction of beta-adrenoceptor density and evaluation of positive isotropic responses in isolated, diseased human myocardium. Eur Heart J 9:844–852

    Google Scholar 

  2. Böhm M, Gierschik P, Jakobs KH, Pieske B, Schnabel P, Ungerer M, Erdmann E (1990) Increase of Giα in human hearts with dilated but not ischemic cardiomyopathy. Circulation 82:1249–1265

    Google Scholar 

  3. Bowditch HP (1871) Über die Eigenthümlichkeiten der Reizbarkeit, welche die Muskelfasern des Herzens zeigen. Ber Sächs Ges (Akad) Wiss 652–689

  4. Bristow MR, Ginsburg R, Minobe W, Cubiciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 307:205–211

    CAS  PubMed  Google Scholar 

  5. Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R, Zera P, Menlove R, Shah P, Jamieson S, Stinson EB (1986) β1- and β2-Adrenergic receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective β1-receptor down-regulation in heart failure. Circ Res 59:297–309

    Google Scholar 

  6. Brodde OE, Zerkowski HR, Borst HG, Maier W, Michel MC (1989) Drug- and disease-induced changes of human cardiac β1- and β2-adrenoceptors. Eur Heart J [Suppl B] 10:38–44

    Google Scholar 

  7. Chidsey CA, Harrison DC, Braunwald E (1962) Augmentation of the plasma noradrenaline response to exercise in patients with congestive heart failure. N Engl J Med 267:650–654

    Google Scholar 

  8. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T (1984) Plasma noradrenaline as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311:819–823

    CAS  PubMed  Google Scholar 

  9. Feldman AM, Copelas L, Gwathmey JK, Philips P, Warren SE, Schoen FJ, Grossman W, Morgan JP (1987) Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 75:331–339

    Google Scholar 

  10. Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA, Van Dop C (1988) Increase of the 40,0001 mol wt pertussis toxin substrate (G protein) in the failing human heart. J Clin Invest 82:189–197

    Google Scholar 

  11. Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP (1987) Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 61:70–76

    CAS  PubMed  Google Scholar 

  12. Gwathmey JK, Slawsky MT, Hajjar RJ, Briggs GM, Morgan JP (1990) Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest 85:1599–1613

    Google Scholar 

  13. Gwathmey JK, Warren SE, Briggs GM, Copelas L, Feldman MD, Phillips PJ, Callahan M Jr, Schoen FJ, Grossman W, Morgan JP (1991) Diastolic dysfunction in hypertrophic cardiomyopathy. J Clin Invest 87:1023–1031

    Google Scholar 

  14. Katz AM (1986) Potential deleterious effects of inotropic agents in the therapy of chronic heart failure. Circulation [Suppl III] 73:184–190

    Google Scholar 

  15. Kirchberger MA, Tada M, Katz AM (1974) Adenosine 3′:5′-monophosphate-dependent protein kinase-Katalyzed phosphorylation reaction and its relationship to calcium transport on cardiac sarcoplasmic reticulum. J Biol Chem 249:6166–6173

    Google Scholar 

  16. Movsesian MA (1988) Calcium uptake and release by cardiac sarcoplasmic reticulum. Heart Failure 10:259–264

    Google Scholar 

  17. Movsesian MA, Bristow MR, Krall J (1989) Ca2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy. Circ Res 65:1141–1144

    Google Scholar 

  18. Movsesian MA, Colyer J, Wang JH, Krall J (1990) Phospholamban-mediated stimulation of Ca2+ uptake in sarcoplasmic reticulum from normal and failing hearts. J Clin Invest 85:1698–1702

    Google Scholar 

  19. Mulieri LA, Hasenfuss G, Ittleman F, Allen PD, Blanchard EM, Alpert NR (1989) Alterations in the force-frequency. Relation in stage III–IV failing human myocardium (abstract). Circulation 80:4

    Google Scholar 

  20. Neumann J, Scholz H, Döring V, Schmitz W, Meyerinck L v, Kalmar P (1988) Increase in myocardial Gi-proteins in heart failure. Lancet II:936–937

    Google Scholar 

  21. Packer M (1988) Neurohormonal interactions and adaptations in congestive heart failure. Circulation 77:721–730

    Google Scholar 

  22. Thomas JA, Marks BH (1978) Plasma noradrenaline in congestive heart failure. A J Cardiol 41:233–243

    Google Scholar 

  23. Wallenstein S, Zucker CL, Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47:1–9

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Supported by the Deutsche Forschungsgemeinschaft (Bo 896/1-2)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Böhm, M., La Rosée, K., Schmidt, U. et al. Force-frequency relationship and inotropic stimulation in the nonfailing and failing human myocardium: implications for the medical treatment of heart failure. Clin Investig 70, 421–425 (1992). https://doi.org/10.1007/BF00235525

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00235525

Key words

Navigation